BIOREM Inc.
BRM.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.82M | 2.59M | 2.27M | 1.60M | 474.30K |
| Total Depreciation and Amortization | 389.40K | 290.40K | 276.60K | 282.70K | 184.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.33M | 873.80K | 692.70K | 494.10K | -9.60K |
| Change in Net Operating Assets | -1.53M | -98.40K | -516.30K | -2.02M | 1.68M |
| Cash from Operations | 4.01M | 3.65M | 2.72M | 362.30K | 2.33M |
| Capital Expenditure | -183.30K | -362.90K | -631.40K | -412.60K | -545.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -183.30K | -362.90K | -631.40K | -412.60K | -545.70K |
| Total Debt Issued | -- | -365.00K | -180.00K | 0.00 | 0.00 |
| Total Debt Repaid | -697.00K | -1.46M | -1.45M | -1.40M | -1.50M |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 69.00K | 69.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -512.80K | -1.36M | -1.22M | -990.40K | -1.07M |
| Foreign Exchange rate Adjustments | 308.50K | -189.10K | 13.00K | -66.30K | -1.60M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.62M | 1.75M | 890.00K | -1.11M | -887.10K |
